Mabion S.A. Logo

Mabion S.A.

ISIN: PLMBION00016 | Ticker: MAB | LEI: 259400KG5JVQPPZL6X53
Sector: Health CareSub-Industry: Biotechnology
Country: Poland

About Mabion S.A.

Company Description

Our company was established by four domestic pharmaceutical companies: Celon Pharma from Łomianki, Polfarmex from Kutno, IBSS Biomed from Kraków and Genexo from Warsaw (now a portfolio company of Twiti Investments) and two entities conducting scientific research in the field of biotechnology: BioCentrum and Biotech Consulting.

We launched our company when the biotechnology sector in Poland was still non-existent, which gave us a unique opportunity to lay foundations for this industry in our country. We started in a small laboratory in the center of Łódź, and now we have two fully equipped modern centers: one for research and development, and the other for science and production.

Year founded

2007

Served area

Worldwide

Headquarters

Gen. M. Langiewicza 60, 95-050 Konstantynów Łódzki – Poland

Filings & Publications

Sign up and we will give you access!

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

PLMBION00016

LEI

259400KG5JVQPPZL6X53

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Warsaw Stock Exchange

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.